The following figures are internal build and audit records used for diligence and pilot scoping. They do not replace wet-lab testing, clinical review, external security certification, patent legal opinion, or customer production approval.
55 parts55 completed technical disclosure parts and 7,450 internally drafted protection elements. Parts 1–30 were submitted in connection with USPTO Provisional Application No. 64/129,790. Submission confirmation has been received for Part 1; Parts 2–30 await confirmation. Parts 31–55 remain confidential and unsubmitted. No granted or examined patent claims are asserted.
7,450internally drafted protection elements across the 55 completed technical disclosure parts. Filing coverage and legal status must be verified part by part.
200+RBFVN mathematics papers addressing 6 Clay Millennium Prize Problems — Hodge, BSD, Riemann, Yang–Mills, Navier–Stokes, P vs NP. Preprints — Clay adjudication governed separately.
87+publicly accessible RIQG physics preprints and research records on Zenodo covering quantum gravity, Standard Model geometry, holographic entropy, and the Vi law cosmological constant. These records are not presented as journal-accepted or peer-reviewed publications unless a specific work is documented separately.
64application domains internally mapped in the cross-domain platform, spanning scales from atomic-scale defects to planetary Earth-system research. Domain mapping does not imply equal maturity, validation, regulatory status, or filing coverage.
100+internally recorded platform modules across twelve domain clusters. Implementation status, test coverage, audit depth, and customer readiness vary by module and must be verified from the applicable evidence package.
120+Rust crates and internal platform components recorded in the audited repository track
1,000+material candidates screened across quantum materials, semiconductors, and superconductors in the internal dry-lab pipeline. Compute and infrastructure requirements depend on the declared workflow and must be verified per run.
96 / 96quantum defect candidates converged through the internal geometric screening pipeline — top candidate score 97.59 / 100
253preregistered drug-candidate packages with molecular identity controls, ADMET proxy, novelty boundary, and CRO-ready dossier — prepared for expert review and experimental handoff
325CRO-style scientific evidence packages in the internal drug-discovery research track
49protein targets covered in the biopharma dry-lab evidence layer across 7 therapeutic areas: oncology, cardiovascular, infectious disease, inflammation, metabolic, neurological, cardiac
43 / 43held-out native reasoning-cycle cases closed in the recorded internal evaluation suite
232tests passing across 8 physical simulation modules — CFD, plasma, structural fatigue, seismic. SHA-256 certificate per run. No HPC required.
227tests passing across 8 financial and economic risk modules — Basel III LCR gate, supply chain SPOF detection, NERC grid gate, CHIPS Act / EU CRMA regulatory flags
195tests passing across 7 Earth-system hazard modules — AMOC bifurcation, Arctic albedo, Amazon-permafrost cascade, seismic precursor detection
Research target≥10⁶ assessments per second is an internal BPUQ architecture target, not a measured hardware result. No fabricated BPUQ device, selected production substrate, or measured throughput is claimed.